Discovery Life Sciences
Discovery Life Sciences is the global market leader in the analysis, procurement and distribution of biospecimens and a leading lab services organization specializing in genomic, cellular and histology-based scientific services and related bioinformatics for the pharmaceutical, biotechnology and diagnostics industries. Water Street merged Conversant Bio, Discovery Life Sciences and Folio Bio to create the company in 2018. Shortly thereafter, Discovery launched a major expansion in Europe to cement its position as a global leader. In 2019, the company added the renowned Genomic Services Laboratory of the HudsonAlpha Institute for Biotechnology and acquired Qualtek Molecular Laboratories. Today, Discovery offers a uniquely powerful suite of solutions that includes one of the world's largest commercial biorepositories and biospecimen networks, the HudsonAlpha Discovery sequencing and bioinformatics laboratory, and innovative flow cytometry and cell-based laboratory services. Water Street is working closely with Discovery's management team, led by CEO Glenn Bilawsky, to further grow Discovery's offering .